documents: FDA-1998-N-1290-0006
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1998-N-1290-0006 | FDA | FDA-1998-N-1290 | OMB Review on 5/31/02 - [New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible] - Reference | Supporting & Related Material | REF-Reference (internal unless indicated) | 2009-04-23T04:00:00Z | 2009 | 4 | 2009-04-24T00:57:33Z | 0 | 0 | 09000064805a6f3f |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref